Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Distinct glutamatergic projections of the posteroventral medial amygdala play different roles in arousal and anxiety
Ying Li, Yuchen Deng, Yifei Zhang, Dan Xu, Xuefen Zhang, Yue Li, Yidan Li, Ming Chen, Yuxin Wang, Jiyan Zhang, Like Wang, Yufeng Cang, Peng Cao, Linlin Bi, Haibo Xu
Ying Li, Yuchen Deng, Yifei Zhang, Dan Xu, Xuefen Zhang, Yue Li, Yidan Li, Ming Chen, Yuxin Wang, Jiyan Zhang, Like Wang, Yufeng Cang, Peng Cao, Linlin Bi, Haibo Xu
View: Text | PDF
Research Article Neuroscience

Distinct glutamatergic projections of the posteroventral medial amygdala play different roles in arousal and anxiety

  • Text
  • PDF
Abstract

Sleep disturbance usually accompanies anxiety disorders and exacerbates their incidence rates. The precise circuit mechanisms remain poorly understood. Here, we found that glutamatergic neurons in the posteroventral medial amygdala (MePVGlu neurons) are involved in arousal and anxiety-like behaviors. Excitation of MePVGlu neurons not only promoted wakefulness but also increased anxiety-like behaviors. Different projections of MePVGlu neurons played various roles in regulating anxiety-like behaviors and sleep-wakefulness. MePVGlu neurons promoted wakefulness through the MePVGlu/posteromedial cortical amygdaloid area (PMCo) pathway and the MePVGlu/bed nucleus of the stria terminals (BNST) pathway. In contrast, MePVGlu neurons increased anxiety-like behaviors through the MePVGlu/ventromedial hypothalamus (VMH) pathway. Chronic sleep disturbance increased anxiety levels and reduced reparative sleep, accompanied by the enhanced excitability of MePVGlu/PMCo and MePVGlu/VMH circuits but suppressed responses of glutamatergic neurons in the BNST. Inhibition of the MePVGlu neurons could rescue chronic sleep deprivation–induced phenotypes. Our findings provide important circuit mechanisms for chronic sleep disturbance–induced hyperarousal response and obsessive anxiety-like behavior and are expected to provide a promising strategy for treating sleep-related psychiatric disorders and insomnia.

Authors

Ying Li, Yuchen Deng, Yifei Zhang, Dan Xu, Xuefen Zhang, Yue Li, Yidan Li, Ming Chen, Yuxin Wang, Jiyan Zhang, Like Wang, Yufeng Cang, Peng Cao, Linlin Bi, Haibo Xu

×

Figure 7

The effects of chemogenetic inhibition of MePVGlu neurons on wakefulness and anxiety-like behavior.

Options: View larger image (or click on image) Download as PowerPoint
The effects of chemogenetic inhibition of MePVGlu neurons on wakefulness...
(A) Schematic of AAV-CaMKIIa-hM4Di-mCherry/AAV-CaMKIIa-mCherry virus injection and the EEG-EMG recordings. (B) Representative pictures of c-fos (green), mCherry (red), and DAPI (blue) colocalization in the MePV of hM3Dq mice treated with CNO or saline. Scale bar = 500 μm. (C) The 3-hour hypnograms following saline or CNO (1 mg/kg) injections into the AAV-CaMKIIa-mCherry mouse (left panel) and the AAV-CaMKIIa-hM3Dq-mCherry mouse (right panel). (D) Percentages of time spent in each condition for MePV-hM4D and MePV-mCherry mice 3 hours after CNO injection. (E) The 6-hour line charts of the AAV-CaMKIIa-hM3Dq-mCherry mouse (top panel) and the AAV-CaMKIIa-mCherry mouse (bottom panel) following saline or CNO (1 mg/kg) injections. (F) Representative open field test track plots (left). The open field test involved the time spent in the center zone and distance traveled (right). The red frame represents the middle zone. (G) Heatmaps of the EPM test (left) and time spent in the open/closed arms (right). Wilcoxon signed rank test, 2-way RM ANOVA with Holm-Šídák post hoc comparison for D–G. All error bars are SEM. D and E: n = 8 per group, F and G: n = 6 per group. *P < 0.05, **P < 0.01, ***P < 0.001.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts